HeartWare Inc recalls HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of…
- Recall date
- April 29, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1751-2015
- FDA classification
- Class II
- Brand / firm
- HeartWare Inc
- Sold / distributed
- AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NY, OH, OR, PA, SC, TN, TX, UT, and VA, Foreign: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary,…
Why it was recalled
Complaints with the HVAD Discolored and Cracked Driveline Outer Sheath.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.
Get recall alerts
Free email alert whenever HeartWare Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: HeartWare Inc